Pharmacogenomics

Pharmacogenomics is the branch of pharmacology that deals with the influence of genetic variations on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with drug efficacy or toxicity. It aims to develop rational ways to optimise drug treatment according to the patient's genotype, to ensure maximum efficacy and minimal adverse effects. These approaches promise the advent of personalised medicine, in which drugs and drug combinations are optimised for the unique genetic make-up of each individual. Pharmacogenomics is the application of pharmacogenetics to the whole genome, examining the interactions between a single gene and drugs.

 

    Related Conference of Pharmacogenomics

    January 29-30, 2026

    19th World Drug Delivery Summit

    Paris, France
    February 10-11, 2026

    40th World Congress on Pharmacology and Therapeutics

    Barcelona, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    March 24-25, 2026

    11th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France

    Pharmacogenomics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in